July 20, 2005 HOT TOPICS NEWS & INFORMATION: TOOLS FOR: RESOURCES:  >  > Attention Business/Medical Editors: CryoCath Receives European Approval for Arctic Front(TM) System - Catheter and Deflectable Sheath Designed to Treat Atrial Fibrillation - www.cryocath.com Toronto Stock Exchange Symbol: CYT MONTREAL, July 18 /CNW/ - CryoCath Technologies Inc. (TSX:CYT), the global leader in cryotherapy products to treat cardiovascular disease, today announced that it has received the CE Mark regulatory approval for 3 key products: Arctic Front, a catheter designed for the treatment of Atrial Fibrillation (AF), a new generation console designed to work with the Arctic Front catheter and the FlexCath deflectable sheath. These approvals allow the Company to sell these products in all countries of the European Union. The granting of the CE Mark was pri

more...